Status: current, Defined. Date: 28-Feb 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4782291000168119 | Lidocaine (Noridem) (lidocaine hydrochloride 40 mg / 2 mL) injection, 5 x 2 mL ampoules (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4782301000168118 | Lidocaine (Noridem) 2% (40 mg/2 mL) injection, 5 x 2 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lidocaine (Noridem) 2% (40 mg/2 mL) injection, 5 x 2 mL ampoules | Is a | Lidocaine (Noridem) 2% (40 mg/2 mL) injection, 5 x 2 mL ampoules | true | Inferred relationship | Some | ||
| Lidocaine (Noridem) 2% (40 mg/2 mL) injection, 5 x 2 mL ampoules | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Lidocaine (Noridem) 2% (40 mg/2 mL) injection, 5 x 2 mL ampoules | has container type | ampoule | true | Inferred relationship | Some | ||
| Lidocaine (Noridem) 2% (40 mg/2 mL) injection, 5 x 2 mL ampoules | has TP | Lidocaine (Noridem) | true | Inferred relationship | Some | ||
| Lidocaine (Noridem) 2% (40 mg/2 mL) injection, 5 x 2 mL ampoules | has TPUU | Lidocaine (Noridem) 2% (40 mg/2 mL) injection, 2 mL ampoule | true | Inferred relationship | Some | 1041929112 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR